Here, we characterize protumorigenic consequences of WT TP53 LOH in LFS cells and report that these consequences can be abolished by pCAP-mediated mutant p53 reactivation, suggesting that pCAPs may be considered for cancer prevention in LFS mutation carriers. This evidence concerns the gene TP53 and cancer.